JPH0597645A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH0597645A JPH0597645A JP3261987A JP26198791A JPH0597645A JP H0597645 A JPH0597645 A JP H0597645A JP 3261987 A JP3261987 A JP 3261987A JP 26198791 A JP26198791 A JP 26198791A JP H0597645 A JPH0597645 A JP H0597645A
- Authority
- JP
- Japan
- Prior art keywords
- zinc
- cosmetic
- amino acid
- salt
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 46
- 150000003839 salts Chemical class 0.000 claims abstract description 32
- 150000001413 amino acids Chemical class 0.000 claims abstract description 31
- 239000002245 particle Substances 0.000 claims abstract description 13
- GAMIYQSIKAOVTG-UHFFFAOYSA-L zinc;2-aminopentanedioate Chemical compound [Zn+2].[O-]C(=O)C(N)CCC([O-])=O GAMIYQSIKAOVTG-UHFFFAOYSA-L 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 229910052751 metal Inorganic materials 0.000 claims description 26
- 239000002184 metal Substances 0.000 claims description 26
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 12
- 239000004471 Glycine Substances 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical group [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
- 239000011701 zinc Substances 0.000 claims description 5
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 235000001014 amino acid Nutrition 0.000 abstract description 33
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract description 6
- 235000004279 alanine Nutrition 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 6
- 150000003751 zinc Chemical class 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract description 3
- 239000004472 Lysine Substances 0.000 abstract description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract description 3
- 239000004474 valine Substances 0.000 abstract description 3
- 239000012190 activator Substances 0.000 abstract description 2
- 239000011248 coating agent Substances 0.000 abstract description 2
- 238000000576 coating method Methods 0.000 abstract description 2
- 239000003925 fat Substances 0.000 abstract description 2
- 239000004615 ingredient Substances 0.000 abstract description 2
- 239000003921 oil Substances 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000000344 soap Substances 0.000 abstract description 2
- 238000004381 surface treatment Methods 0.000 abstract description 2
- 229940071566 zinc glycinate Drugs 0.000 abstract 2
- UOXSXMSTSYWNMH-UHFFFAOYSA-L zinc;2-aminoacetate Chemical compound [Zn+2].NCC([O-])=O.NCC([O-])=O UOXSXMSTSYWNMH-UHFFFAOYSA-L 0.000 abstract 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- 229930182817 methionine Natural products 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 16
- 238000009472 formulation Methods 0.000 description 15
- 230000000475 sunscreen effect Effects 0.000 description 15
- -1 aliphatic amino acid Chemical class 0.000 description 14
- 239000000516 sunscreening agent Substances 0.000 description 14
- 239000002253 acid Substances 0.000 description 13
- 239000000843 powder Substances 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 9
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 9
- 150000007513 acids Chemical class 0.000 description 8
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 8
- HGSXDBRNFBJIMX-UHFFFAOYSA-N 2-aminoacetic acid;zinc Chemical group [Zn].NCC(O)=O HGSXDBRNFBJIMX-UHFFFAOYSA-N 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000010419 fine particle Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 229960000541 cetyl alcohol Drugs 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 235000013922 glutamic acid Nutrition 0.000 description 4
- 239000004220 glutamic acid Substances 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 229960001679 octinoxate Drugs 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 235000012239 silicon dioxide Nutrition 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 3
- 239000010445 mica Substances 0.000 description 3
- 229910052618 mica group Inorganic materials 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 230000003405 preventing effect Effects 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 239000004287 Dehydroacetic acid Substances 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 239000004288 Sodium dehydroacetate Substances 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000019258 dehydroacetic acid Nutrition 0.000 description 2
- 229940061632 dehydroacetic acid Drugs 0.000 description 2
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000014593 oils and fats Nutrition 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 2
- 229940079839 sodium dehydroacetate Drugs 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- DDKJKQVNNATMAD-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;zinc Chemical compound [Zn].NCCCC[C@H](N)C(O)=O DDKJKQVNNATMAD-JEDNCBNOSA-N 0.000 description 1
- HZKRMDUDIQVKOJ-WCCKRBBISA-N (2s)-2-amino-3-methylbutanoic acid;zinc Chemical compound [Zn].CC(C)[C@H](N)C(O)=O HZKRMDUDIQVKOJ-WCCKRBBISA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LRZBIPQJHILPJI-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-(2,3-dihydroxypropyl)octadecanoate Chemical compound CCCCCCCCCCCCCCCCC(CC(O)CO)C(=O)OCC(O)CO LRZBIPQJHILPJI-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- BKZCZANSHGDPSH-KTKRTIGZSA-N [3-(2,3-dihydroxypropoxy)-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)CO BKZCZANSHGDPSH-KTKRTIGZSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- QWPNJOHZHSJFIY-UHFFFAOYSA-N octyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCC QWPNJOHZHSJFIY-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940110280 zinc methionine Drugs 0.000 description 1
- CNMFGFBWPBBGKX-SCGRZTRASA-L zinc;(2s)-2-amino-4-methylsulfanylbutanoate Chemical compound [Zn+2].CSCC[C@H](N)C([O-])=O.CSCC[C@H](N)C([O-])=O CNMFGFBWPBBGKX-SCGRZTRASA-L 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は化粧料に関する。さらに
詳しくはアミノ酸金属塩を有効成分として配合すること
を特徴とする、有害な紫外線から皮膚を保護するだけで
なく、白さが無く透明感の高い自然な仕上がりで、かつ
使用感の良い化粧料に関する。FIELD OF THE INVENTION The present invention relates to cosmetics. More specifically, it is a cosmetic product characterized by containing an amino acid metal salt as an active ingredient, which not only protects the skin from harmful ultraviolet rays, but also has a natural finish with high transparency without whiteness and a good usability. Regarding
【0002】[0002]
【従来の技術および発明が解決しようとする課題】従来
より酸化チタン、酸化亜鉛などの金属酸化物を有効成分
として含有する種々の化粧料は紫外線に対するすぐれた
防御作用を有することが知られている。しかしながら、
これらの化粧料は被覆力が大きすぎるため皮膚に塗布し
たばあいその化粧膜が白くなり、厚化粧を呈しているよ
うな不自然な仕上がりとなる。またこれらの粉末の欠点
を無くするため、または紫外線に対する防御作用をさら
に高めるために化粧料に配合する酸化チタンなどの微粒
子粉末の粒子は、該粒子が細か過ぎるため皮膚に塗布し
たばあいスジ引きの原因となったり皮溝、毛穴に粉が入
り込み、不自然な仕上がりになるなどの問題があった。2. Description of the Related Art Conventionally, various cosmetics containing metal oxides such as titanium oxide and zinc oxide as active ingredients are known to have an excellent protective action against ultraviolet rays. .. However,
Since these cosmetics have too large a covering power, when they are applied to the skin, the cosmetic film becomes white, resulting in an unnatural finish such as a thick makeup. Further, in order to eliminate the defects of these powders or to further enhance the protective action against ultraviolet rays, particles of fine particle powder such as titanium oxide to be incorporated into cosmetics are streaked when applied to the skin because the particles are too fine. There was a problem such as the cause of the above and powder entering the skin groove and pores, resulting in an unnatural finish.
【0003】[0003]
【課題を解決するための手段】そこで本発明者らはかか
る点に鑑み、前記課題を解決すべく鋭意研究を重ねた結
果、アミノ酸金属塩を有効成分として配合することによ
りすぐれた紫外線遮断効果を有するだけでなく、白さが
無く透明感の高い自然な仕上がりで、かつ使用感の良い
化粧料がえらえることを見出し、本発明を完成するに至
った。In view of the above points, the inventors of the present invention have conducted extensive studies to solve the above problems, and as a result, by adding an amino acid metal salt as an active ingredient, an excellent ultraviolet blocking effect was obtained. The present invention has been completed based on the finding that a cosmetic having not only whiteness but also a natural finish with high transparency and a good feeling of use can be obtained.
【0004】すなわち本発明は、アミノ酸金属塩を有効
成分として配合することを特徴とする化粧料に関する。
さらに本発明は、アミノ酸金属塩の配合量が化粧料全量
の0.01〜95重量%であること、アミノ酸金属塩の粒子径
が0.01〜50μmであること、アミノ酸金属塩がグリシン
亜鉛であることおよびアミノ酸金属塩がグルタミン酸亜
鉛であることを特徴とする化粧料に関する。That is, the present invention relates to a cosmetic composition containing an amino acid metal salt as an active ingredient.
Furthermore, the present invention provides that the content of the amino acid metal salt is 0.01 to 95% by weight of the total amount of the cosmetic, the particle size of the amino acid metal salt is 0.01 to 50 μm, the amino acid metal salt is glycine zinc, and the amino acid The present invention relates to a cosmetic, wherein the metal salt is zinc glutamate.
【0005】[0005]
【実施例】本発明において用いられるアミノ酸金属塩の
粒子径は0.01〜50μm、好ましくは0.1 〜20μmであ
る。粒子径が0.01μm以下であれば、皮溝、毛穴に粉が
入り込み不自然な仕上がりとなる。また50μm以上であ
れば、皮膚でざらついた異和感を有する。EXAMPLE The particle size of the amino acid metal salt used in the present invention is 0.01 to 50 μm, preferably 0.1 to 20 μm. If the particle size is 0.01 μm or less, powder will enter the skin grooves and pores, resulting in an unnatural finish. Further, if it is 50 μm or more, the skin has a feeling of strangeness.
【0006】また該アミノ酸金属塩は化粧料全量の0.01
〜95%(重量%、以下同様)、好ましくは0.1 〜50%配
合される。配合量が0.01%以下であれば前記紫外線遮断
などの期待どおりの効果がえられず、95%以上であれば
白さが目立ち自然な仕上がりの化粧膜がえられない。The amino acid metal salt is 0.01% of the total amount of cosmetics.
~ 95% (wt%, the same applies below), preferably 0.1 to 50%. If the blending amount is 0.01% or less, the expected effects such as the above-mentioned ultraviolet ray blocking cannot be obtained, and if the blending amount is 95% or more, white makeup is not noticeable and a natural finish cosmetic film cannot be obtained.
【0007】アミノ酸金属塩のアミノ酸としては、脂肪
族アミノ酸、芳香族アミノ酸または複素環式アミノ酸の
いずれでもよい。たとえば、グリシン、アラニン、バリ
ンなどのモノアミノモノカルボン酸;セリン、トレオニ
ンなどのオキシアミノ酸;システイン、メチオニオンな
どの含イオウアミノ酸;アスパラギン酸、グルタミン酸
などのモノアミノジカルボン酸;リジンなどのジアミノ
モノカルボン酸などの脂肪族アミノ酸などが好ましい例
としてあげられる。これらの中でも粉末の外観色、安定
性、使用感などの面から考えてグリシン、アラニン、グ
ルタミン酸がとくに好ましい。The amino acid of the amino acid metal salt may be an aliphatic amino acid, an aromatic amino acid or a heterocyclic amino acid. For example, monoaminomonocarboxylic acids such as glycine, alanine, and valine; oxyamino acids such as serine and threonine; sulfur-containing amino acids such as cysteine and methionion; monoaminodicarboxylic acids such as aspartic acid and glutamic acid; diaminomonocarboxylic acids such as lysine. Aliphatic amino acids such as are preferred examples. Among these, glycine, alanine, and glutamic acid are particularly preferable in view of the appearance color of powder, stability, and feeling of use.
【0008】アミノ酸金属塩の金属としてはたとえば、
Mg、Ca、Baなどのアルカリ土類金属、Zn、A
l、Pbなどがあげられるが、これらの中でも化粧料に
配合したばあいの安全性、安定性の点からZnがとくに
好ましい。The metal of the amino acid metal salt is, for example,
Alkaline earth metals such as Mg, Ca, Ba, Zn, A
Among these, Zn is particularly preferable from the viewpoints of safety and stability when incorporated into cosmetics.
【0009】アミノ酸金属塩としては亜鉛塩を例にとっ
て示すと、グリシン亜鉛、グルタミン酸亜鉛、アラニン
亜鉛、バリン亜鉛、メチオニン亜鉛、リジン亜鉛などが
好ましく用いられる。本発明の化粧料には前記アミノ酸
金属塩を単独で配合してもよくまたは2種以上を配合し
てもよい。Taking zinc salts as examples of amino acid metal salts, zinc glycine, zinc glutamate, zinc alanine, zinc valine, zinc methionine, zinc lysine and the like are preferably used. The amino acid metal salt may be blended alone or in combination of two or more in the cosmetic of the present invention.
【0010】なおアミノ酸金属塩を化粧料に配合するば
あい、その特性を活かし、分散性、使用性を向上させる
目的で、一般に既知の油脂原料などによる表面被覆処
理、活性剤処理、金属石ケン処理などの表面処理を行な
ってから配合することも可能である。When an amino acid metal salt is blended in a cosmetic composition, in order to take advantage of its properties and improve the dispersibility and usability, a surface coating treatment with a generally known raw material of fats and oils, an activator treatment, a metal soap It is also possible to mix after performing surface treatment such as treatment.
【0011】また本発明の化粧料には該アミノ酸金属塩
のほかにも一般に化粧料に用いられている油性成分(油
脂類など)、水性成分(保湿剤など)、高分子化合物、
界面活性剤、香料、防腐剤・酸化防止剤、紫外線吸収
剤、顔料類、そのほかの各種成分が用途に応じて適宜配
合される。In addition to the amino acid metal salt, the cosmetics of the present invention include, in addition to the amino acid metal salts, oily components (oils and fats) generally used in cosmetics, aqueous components (humectants, etc.), polymer compounds,
Surfactants, fragrances, preservatives / antioxidants, ultraviolet absorbers, pigments, and other various components are appropriately blended according to the application.
【0012】前記油性成分(油脂類など)としてはたと
えば、オリーブ油、ヒマシ油、スクワラン、流動パラフ
ィン、パラフィン、セチルアルコール、ステアリルアル
コール、ステアリン酸、オレイン酸、イソプロピルパル
ミテート、イソプロピルミリステート、ミリスチン酸オ
クチルドデシル、リンゴ酸ジイソステアレート、水添レ
シチン、ミツロウ、ラノリン、メチルポリシロキサンな
どがあげられる。Examples of the oily components (oils and fats) include olive oil, castor oil, squalane, liquid paraffin, paraffin, cetyl alcohol, stearyl alcohol, stearic acid, oleic acid, isopropyl palmitate, isopropyl myristate, octyl myristate. Dodecyl, malic acid diisostearate, hydrogenated lecithin, beeswax, lanolin, methyl polysiloxane and the like can be mentioned.
【0013】前記水性成分(保湿剤など)としてはたと
えば、グリセリン、ソルビット液、プロピレングリコー
ル、1,3-ブチレングリコール、ポリエチレングリコール
などがあげられる。Examples of the aqueous component (humectant, etc.) include glycerin, sorbit solution, propylene glycol, 1,3-butylene glycol, polyethylene glycol and the like.
【0014】前記高分子化合物としてはたとえば、キサ
ンタンガム、アラビアガム、カラギーナン、トラガン
ト、カルボキシビニルポリマー、ポリビニルアルコー
ル、ポリビニルピロリドン、ポリアクリル酸ナトリウ
ム、メチルセルロース、エチルセルロースなどがあげら
れる。Examples of the polymer compound include xanthan gum, gum arabic, carrageenan, tragacanth, carboxyvinyl polymer, polyvinyl alcohol, polyvinylpyrrolidone, sodium polyacrylate, methyl cellulose, ethyl cellulose and the like.
【0015】前記界面活性剤としてたとえば、ソルビタ
ンモノステアレート、ソルビタンモノパルミテート、ジ
グリセリルモノステアレート、ジグリセリルモノオレエ
ート、グリセリルモノステアレート、ポリオキシエチレ
ングリセリンモノステアレート、ポリオキシエチレンソ
ルビタンモノラウレート、ポリオキシエチレン硬化ヒマ
シ油などがあげられる。Examples of the surfactant include sorbitan monostearate, sorbitan monopalmitate, diglyceryl monostearate, diglyceryl monooleate, glyceryl monostearate, polyoxyethylene glycerin monostearate, polyoxyethylene sorbitan monosate. Examples include laurate and polyoxyethylene hydrogenated castor oil.
【0016】前記防腐剤・酸化防止剤としてはたとえ
ば、パラオキシ安息香酸エステル、デヒドロ酢酸(およ
びその塩類)、ソルビン酸(およびその塩類)、塩化リ
ゾチーム、ブチルヒドロキシトルエン、ブチルヒドロキ
シアニソールなどがあげられる。Examples of the antiseptic / antioxidant include paraoxybenzoic acid ester, dehydroacetic acid (and its salts), sorbic acid (and its salts), lysozyme chloride, butylhydroxytoluene, butylhydroxyanisole and the like.
【0017】前記紫外線吸収剤としてはたとえば、ウロ
カニン酸、ウロカニン酸エチル、オキシベンゾン、サリ
チル酸オクチル、ジヒドロキシベンゾフェノン、パラア
ミノ安息香酸、パラジメチルアミノ安息香酸オクチル、
メトキシケイ皮酸オクチルなどがあげられる。Examples of the ultraviolet absorber include urocanic acid, ethyl urocanate, oxybenzone, octyl salicylate, dihydroxybenzophenone, paraaminobenzoic acid, octyl paradimethylaminobenzoate,
Examples include octyl methoxycinnamate.
【0018】前記顔料類としてはたとえば、タール色
素、タルク、カオリン、マイカ、セリサイト、酸化チタ
ン、雲母チタン、黄酸化鉄、ベンガラ、黒酸化鉄、ベン
トナイト、酸化亜鉛、酸化マグネシウム、ケイ酸、ナイ
ロンパウダーなどがあげられる。Examples of the pigments include tar pigments, talc, kaolin, mica, sericite, titanium oxide, titanium mica, iron oxide yellow, red iron oxide, black iron oxide, bentonite, zinc oxide, magnesium oxide, silicic acid, nylon. Examples include powder.
【0019】前記そのほかの各種成分としてはたとえ
ば、ヒアルロン酸ナトリウム、タンパク質、ペプチド
類、アミノ酸類、ビタミン、生薬エキスなどがあげられ
る。Examples of the various other components include sodium hyaluronate, proteins, peptides, amino acids, vitamins, crude drug extracts and the like.
【0020】これらの化粧料成分の各配合量は目的とす
る化粧料の用途などにより異なるため一概には決定でき
ず、用途に応じて適宜配合されることが好ましい。The blending amount of each of these cosmetic ingredients cannot be unconditionally determined because it varies depending on the intended use of the cosmetic and the like, and it is preferably blended appropriately according to the intended use.
【0021】本発明の化粧料の形態は任意であり限定さ
れるものではないが、すぐれた紫外線遮断効果で日焼け
を防止するなどの性質を有するため、たとえばクリー
ム、乳液、ローションなどの基礎化粧品、パウダーファ
ンデーション、リキッドファンデーションなどのメイク
アップ化粧品などをあげることができる。The form of the cosmetic of the present invention is arbitrary and is not limited, but it has the property of preventing sunburn due to its excellent UV-blocking effect, so that it can be used as a basic cosmetic such as cream, emulsion, lotion, etc. Makeup cosmetics such as powder foundation and liquid foundation can be given.
【0022】つぎに実施例をあげて本発明についてさら
に詳しく説明するが、本発明はこれらにのみ限定される
ものではない。Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited thereto.
【0023】 処方例1(日焼け止めクリーム) [A成分] (%) スクワラン 10.0 イソプロピルパルミテート 5.0 水添レシチン 3.0 セチルアルコール 2.0 ジブチルヒドロキシトルエン 0.04 メトキシケイ皮酸オクチル 5.0 [B成分] 精製水 残量 プロピレングリコール 8.0 パラアミノ安息香酸エステル 0.2 [C成分] グリシン亜鉛(平均粒径1.6 μm) 2.0 (製造法)B成分を80℃に加温し、C成分を添加してホ
モミキサーにて均一に分散した(D成分)。A成分を80
℃に加温し、D成分を添加してホモミキサーにて均一に
分散、乳化した。その後30℃まで撹拌冷却してクリーム
をえた。Formulation 1 (sunscreen cream) [A component] (%) Squalane 10.0 Isopropyl palmitate 5.0 Hydrogenated lecithin 3.0 Cetyl alcohol 2.0 Dibutylhydroxytoluene 0.04 Octyl methoxycinnamate 5.0 [B component] Purified water Remaining amount Propylene Glycol 8.0 Para-aminobenzoic acid ester 0.2 [Component C] Glycine zinc (average particle size 1.6 μm) 2.0 (Production method) Component B was heated to 80 ° C., component C was added, and the mixture was uniformly dispersed with a homomixer ( D component). A component is 80
The mixture was heated to ° C, the component D was added, and the mixture was uniformly dispersed and emulsified with a homomixer. Then, the mixture was stirred and cooled to 30 ° C. to obtain a cream.
【0024】 処方例2(日焼け止め乳液) [A成分] (%) 流動パラフィン 5.0 ステアリン酸 4.0 セチルアルコール 1.0 ソルビタンモノステアレート 1.0 イソプロピルミリステート 1.0 メトキシケイ皮酸オクチル 3.0 ジブチルヒドロキシトルエン 0.02 [B成分] 精製水 残量 1,3-ブチレングリコール 4.0 パラオキシ安息香酸エステル 0.2 水酸化カリウム 0.2 デヒドロ酢酸ナトリウム 0.05 キサンタンガム 0.2 [C成分] グリシン亜鉛(平均粒径1.6 μm) 1.0 (製造法)B成分を80℃に加温し、C成分を添加してホ
モミキサーにて均一に分散した(D成分)。A成分を80
℃に加温し、D成分を添加してホモミキサーにて均一に
分散、乳化した。その後30℃まで撹拌冷却して乳液をえ
た。Formulation Example 2 (Sunscreen milky lotion) [A component] (%) Liquid paraffin 5.0 Stearic acid 4.0 Cetyl alcohol 1.0 Sorbitan monostearate 1.0 Isopropyl myristate 1.0 Octyl methoxycinnamate 3.0 Dibutylhydroxytoluene 0.02 [B component] Purified water Residual amount 1,3-butylene glycol 4.0 Paraoxybenzoic acid ester 0.2 Potassium hydroxide 0.2 Sodium dehydroacetate 0.05 Xanthan gum 0.2 [C component] Glycine zinc (average particle size 1.6 μm) 1.0 (Manufacturing method) After heating, the C component was added and uniformly dispersed by a homomixer (D component). A component is 80
The mixture was heated to ° C, the component D was added, and the mixture was uniformly dispersed and emulsified with a homomixer. Then, the mixture was stirred and cooled to 30 ° C. to obtain an emulsion.
【0025】 処方例3(日焼け止めローション) [A成分] (%) 精製水 残量 グリセリン 5.0 ソルビット液 4.0 プロピレングリコール 5.0 パラオキシ安息香酸エステル 0.2 エチルアルコール 5.0 キサンタンガム 0.01 ヒアルロン酸ナトリウム 0.05 生薬エキス 1.0 [B成分] グルタミン酸亜鉛(平均粒径3.1 μm) 1.0 (製造法)A成分を全量撹拌溶解後、B成分を添加し均
一に分散してローションをえた。Formulation Example 3 (Sunscreen lotion) [A component] (%) Remaining amount of purified water Glycerin 5.0 Solbit solution 4.0 Propylene glycol 5.0 Paraoxybenzoic acid ester 0.2 Ethyl alcohol 5.0 Xanthan gum 0.01 Sodium hyaluronate 0.05 Crude drug extract 1.0 [B component ] Zinc glutamate (average particle size: 3.1 μm) 1.0 (Production method) After completely dissolving the component A with stirring, the component B was added and uniformly dispersed to obtain a lotion.
【0026】 処方例4(日焼け止めリキッドファンデーション) [A成分] (%) 流動パラフィン 4.0 ミリスチン酸オクチルドデシル 1.5 メトキシケイ皮酸オクチル 3.0 ステアリン酸 2.0 セチルアルコール 0.5 ジクリセリルモノステアレート 1.5 ビタミンE 0.2 [B成分] 精製水 残量 1,3-ブチレングリコール 10.0 パラオキシ安息香酸エステル 0.2 トリエタノールアミン 0.4 ベントナイト 2.0 エチルアルコール 5.0 [C成分] タルク 0.9 ケイ酸 0.3 酸化チタン 2.0 グリシン亜鉛(平均粒径3.7 μm) 5.0 黄酸化鉄 0.9 ベンガラ 0.2 黒酸化鉄 0.1 (製造法)C成分を粉砕器にて均一に分散後、75℃に加
温したB成分に混合しホモミキサーにて充分に分散した
(D成分)。A成分を75℃に加熱しD成分を添加後ホモ
ミキサーにて均一に分散、乳化した。その後30℃まで撹
拌冷却してリキッドファンデーションをえた。Formulation 4 (Sunscreen liquid foundation) [A component] (%) Liquid paraffin 4.0 Octyl dodecyl myristate 1.5 Octyl methoxycinnamate 3.0 Stearic acid 2.0 Cetyl alcohol 0.5 Dichryceryl monostearate 1.5 Vitamin E 0.2 [B Components] Purified water Remaining amount 1,3-butylene glycol 10.0 Paraoxybenzoic acid ester 0.2 Triethanolamine 0.4 Bentonite 2.0 Ethyl alcohol 5.0 [C component] Talc 0.9 Silicic acid 0.3 Titanium oxide 2.0 Glycine zinc (average particle size 3.7 μm) 5.0 Yellow iron oxide 0.9 Red iron oxide 0.2 Black iron oxide 0.1 (Production method) C component was uniformly dispersed by a pulverizer, then mixed with B component heated to 75 ° C. and sufficiently dispersed by a homomixer (D component). The component A was heated to 75 ° C., the component D was added, and the mixture was uniformly dispersed and emulsified with a homomixer. Then, the mixture was stirred and cooled to 30 ° C. to obtain a liquid foundation.
【0027】 処方例5(日焼け止めパウダーファンデーション) [A成分] (%) セリサイト 残量 タルク 20.0 カオリン 10.0 ナイロンパウダー 8.0 グルタミン酸亜鉛(平均粒径3.1 μm) 10.0 デヒドロ酢酸ナトリウム 0.1 雲母チタン 5.0 黄酸化鉄 2.4 ベンガラ 1.0 黒酸化鉄 0.1 [B成分] メチルポリシロキサン 7.0 流動パラフィン 2.0 リンゴ酸ジイソステアリル 3.0 パラオキシ安息香酸エステル 0.1 メトキシケイ酸オクチル 0.5 (製造法)A成分を粉砕器にて混合し、加熱溶解したB
成分を添加しさらに粉砕機にて均一に分散した。その後
所定の容器に充填し成型してパウダーファンデーション
をえた。Formulation Example 5 (Sunscreen powder foundation) [A component] (%) Sericite remaining amount Talc 20.0 Kaolin 10.0 Nylon powder 8.0 Zinc glutamate (average particle size 3.1 μm) 10.0 Sodium dehydroacetate 0.1 Mica titanium 5.0 Iron oxide yellow 2.4 Bengal 1.0 Iron oxide black 0.1 [B component] Methyl polysiloxane 7.0 Liquid paraffin 2.0 Diisostearyl malate 3.0 Paraoxybenzoic acid ester 0.1 Octyl methoxysilicate 0.5 (Manufacturing method) A component is mixed with a grinder. And melted by heating B
The ingredients were added and further dispersed uniformly by a pulverizer. Then, it was filled in a predetermined container and molded to obtain a powder foundation.
【0028】比較処方例1(日焼け止めクリーム) 処方例1で用いたグリシン亜鉛のかわりに微粒子酸化チ
タン(平均粒径0.035μm)を2.0 %配合したほかは処
方例1と同様にしてクリームをえた。Comparative Prescription Example 1 (Sunscreen Cream) A cream was obtained in the same manner as in Prescription Example 1 except that 2.0% of fine particle titanium oxide (average particle size 0.035 μm) was added instead of glycine zinc used in Prescription Example 1. ..
【0029】比較処方例2(日焼け止め乳液) 処方例2で用いたグリシン亜鉛のかわりに比較処方例1
で用いたものと同じ微粒子酸化チタンを1.0 %配合した
ほかは処方例2と同様にして乳液をえた。Comparative prescription example 2 (sunscreen emulsion) Instead of the glycine zinc used in prescription example 2, comparative prescription example 1
An emulsion was obtained in the same manner as in Prescription Example 2 except that 1.0% of the same fine particle titanium oxide as used in Example 1 was blended.
【0030】比較処方例3(日焼け止めローション) 処方例3で用いたグルタミン酸亜鉛のかわりに比較処方
例1で用いたものと同じ微粒子酸化チタンを1.0 %配合
したほかは処方例3と同様にしてローションをえた。Comparative prescription example 3 (sunscreen lotion) Same as prescription example 3 except that 1.0% of the same particulate titanium oxide as used in comparative prescription example 1 was used instead of zinc glutamate used in prescription example 3. I got lotion.
【0031】比較処方例4(日焼け止めリキッドファン
デーション) 処方例4で用いたグリシン亜鉛のかわりに比較処方例1
で用いたものと同じ微粒子酸化チタンを5.0 %配合した
ほかは処方例4と同様にしてリキッドファンデーション
をえた。Comparative Prescription Example 4 (Sunscreen Liquid Foundation) Instead of the glycine zinc used in Prescription Example 4, Comparative Prescription Example 1
A liquid foundation was obtained in the same manner as in Formulation Example 4 except that 5.0% of the same fine particle titanium oxide as used in Example 1 was blended.
【0032】比較処方例5(日焼け止めパウダーファン
デーション) 処方例5で用いたグルタミン酸亜鉛のかわりに比較処方
例1で用いたものと同じ微粒子酸化チタンを10.0%配合
したほかは処方例5と同様にしてパウダーファンデーシ
ョンをえた。Comparative prescription example 5 (sunscreen powder foundation) The same as prescription example 5 except that 10.0% of the same fine particle titanium oxide as used in comparative prescription example 1 was blended in place of the zinc glutamate used in prescription example 5. I got a powder foundation.
【0033】処方例1〜5および比較処方例1〜5でえ
られた化粧料について、各々以下に示す試験を行なっ
た。The cosmetics obtained in Formulation Examples 1-5 and Comparative Formulation Examples 1-5 were subjected to the following tests.
【0034】試験例1(日焼け止め指数) 処方例1〜3および比較処方例1〜3でえられた化粧料
については、各々0.2mg/mlになるように溶媒(エタノー
ルまたは水)で均一に分散したのち1cmの石英角セルを
用い波長が290 〜320nm のUV- B領域のスペクトルを
分光光度計(日立製作所製、HITACHI U-3200)で測定し
た。その面積値から以下の式 日焼け止め指数=0.243 ×面積値+1 より各々日焼け止め指数を算出した。Test Example 1 (Sunscreen Index) The cosmetics obtained in Formulation Examples 1 to 3 and Comparative Formulation Examples 1 to 3 were uniformly mixed with a solvent (ethanol or water) to 0.2 mg / ml. After dispersion, the spectrum in the UV-B region with a wavelength of 290 to 320 nm was measured with a spectrophotometer (Hitachi U-3200 manufactured by Hitachi, Ltd.) using a 1 cm quartz square cell. The sunscreen index was calculated from the area value by the following formula: sunscreen index = 0.243 x area value + 1.
【0035】また処方例4、5および比較処方例4、5
でえられた化粧料については、各々5倍量の水で希釈し
たのち10μアプリケーターを用い石英板に均一に塗布し
充分に乾燥させ、波長が290 〜320nm のUV−B領域の
スペクトルを前記分光光度計で測定した。その面積値か
ら前記と同じ式より日焼け止め指数を算出した。これら
の結果を表1に示す。Formulation Examples 4 and 5 and Comparative Formulation Examples 4 and 5
Each of the cosmetics obtained was diluted with 5 times the amount of water, then uniformly applied to a quartz plate using a 10 μ applicator and dried sufficiently, and the spectrum in the UV-B region with a wavelength of 290 to 320 nm was measured by the above-mentioned spectroscopy. It was measured with a photometer. The sunscreen index was calculated from the area value by the same formula as described above. The results are shown in Table 1.
【0036】[0036]
【表1】 [Table 1]
【0037】さらに処方例1〜5および比較処方例1〜
5でえられた化粧料について、各々以下に示すモニター
テストを行なった。Further, Formulation Examples 1-5 and Comparative Formulation Examples 1-
For the cosmetics obtained in No. 5, the following monitor tests were conducted.
【0038】実施例1(日焼け止め効果) 6月の快晴の日に、無作為に選出した25〜40歳の健康な
男性5名、女性5名、計10名のパネラーの皮膚に、化粧
料を各々1cm2 あたり2mg塗布した。日光に2時間皮膚
を照射したのち化粧料を払拭して、日焼けの程度を紅斑
の強弱およびメラニン色素沈着防止効果について、以下
の判定基準に基づいて目視で4段階評価を行なった。結
果を表2に示す。なお、表2の評価は各々10名の評価を
総合的に示したものである。Example 1 (Sunscreen Effect) On a sunny day in June, a panel of 10 healthy panelists, 5 healthy men and 5 females aged 25 to 40, and cosmetics were randomly selected on a sunny day. 2 mg per 1 cm 2 was applied. After irradiating the skin with sunlight for 2 hours, the cosmetics were wiped off, and the degree of sunburn was visually evaluated on the basis of the following criteria with respect to the intensity of erythema and the effect of preventing melanin pigmentation. The results are shown in Table 2. The evaluations in Table 2 are comprehensive evaluations of 10 persons.
【0039】[紅斑の強弱] A:非常に弱い B:弱い C:やや強い D:強い [メラニン色素沈着防止効果] A:非常に良い B:良い C:やや悪い D:悪い[Erythema intensity] A: Very weak B: Weak C: Strongly strong D: Strong [Melanin pigmentation preventing effect] A: Very good B: Good C: Slightly bad D: Bad
【0040】[0040]
【表2】 [Table 2]
【0041】実施例2(使用感) 無作為に選出した30〜50歳の健康な女性30名のパネラー
に各化粧料を通常どおり使用してもらい、処方例1〜3
および比較処方例1〜3でえられた化粧料については表
3に示す6頁目、処方例4、5および比較処方例4、5
でえられた化粧料については表4に示す7項目につい
て、以下の判定基準に基づいて5段階評価を行なった。
結果を表3および表4に示す。なお、表3および表4の
評価は各々30名の評価点の平均値を示したものである。Example 2 (Feeling of Use) Panelists of 30 randomly selected healthy women aged 30 to 50 were asked to use each cosmetic as usual, and prescription examples 1 to 3 were used.
For the cosmetics obtained in Comparative Prescription Examples 1 to 3, page 6 shown in Table 3, Prescription Examples 4, 5 and Comparative Prescription Examples 4, 5
With respect to the cosmetics obtained in the above, the 7 items shown in Table 4 were evaluated in 5 grades based on the following criteria.
The results are shown in Tables 3 and 4. The evaluations in Tables 3 and 4 are the average values of the evaluation points of 30 persons.
【0042】[使用感] 5:非常に良い 4:良い 3:普通 2:やや悪い 1:悪い[Usage] 5: Very good 4: Good 3: Normal 2: Slightly bad 1: Bad
【0043】[0043]
【表3】 [Table 3]
【0044】[0044]
【表4】 [Table 4]
【0045】表1〜4に示すように、本発明の化粧料の
効果は比較処方例に示すような従来の化粧料以上である
ことが分かった。As shown in Tables 1 to 4, it was found that the effect of the cosmetics of the present invention was more than that of the conventional cosmetics as shown in the comparative formulation examples.
【0046】なお、これら実施例1、2のモニターテス
トの結果、皮膚に異常を訴えたものはいなかった。As a result of the monitor test of Examples 1 and 2, none of them complained of abnormality on the skin.
【0047】[0047]
【発明の効果】アミノ酸金属塩が配合された本発明の化
粧料は、高い紫外線遮断効果を有するだけでなく、白さ
が無く透明感の高い自然な仕上がりで、かつ使用感が良
いという効果も奏する。EFFECT OF THE INVENTION The cosmetic of the present invention containing an amino acid metal salt has not only a high UV blocking effect, but also a natural finish with no whiteness and a high transparency, and a good usability. Play.
─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───
【手続補正書】[Procedure amendment]
【提出日】平成3年11月18日[Submission date] November 18, 1991
【手続補正1】[Procedure Amendment 1]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0003[Name of item to be corrected] 0003
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0003】[0003]
【課題を解決するための手段】そこで本発明者らはかか
る点に鑑み、前記課題を解決すべく鋭意研究を重ねた結
果、アミノ酸金属塩を有効成分として配合することによ
りすぐれた紫外線遮断効果を有するだけでなく、白さが
無く透明感の高い自然な仕上がりで、かつ使用感の良い
化粧料がえられることを見出し、本発明を完成するに至
った。In view of the above points, the inventors of the present invention have conducted extensive studies to solve the above problems, and as a result, by adding an amino acid metal salt as an active ingredient, an excellent ultraviolet blocking effect was obtained. not only have, in high natural finish of whiteness is no clarity, and is a good feeling of use cosmetic gills found Rukoto, which resulted in the completion of the present invention.
【手続補正2】[Procedure Amendment 2]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0007[Correction target item name] 0007
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0007】アミノ酸金属塩のアミノ酸としては、脂肪
族アミノ酸、芳香族アミノ酸または複素環族アミノ酸の
いずれでもよい。たとえば、グリシン、アラニン、バリ
ンなどのモノアミノモノカルボン酸;セリン、トレオニ
ンなどのオキシアミノ酸;システイン、メチオニオンな
どの含イオウアミノ酸;アスパラギン酸、グルタミン酸
などのモノアミノジカルボン酸;リジンなどのジアミノ
モノカルボン酸などの脂肪族アミノ酸などが好ましい例
としてあげられる。これらの中でも粉末の外観色、安定
性、使用感などの面から考えてグリシン、アラニン、グ
ルタミン酸がとくに好ましい。[0007] As the amino acids metal salts, aliphatic amino acids, may be any of aromatic amino or heterocyclic group amino acids. For example, monoaminomonocarboxylic acids such as glycine, alanine, and valine; oxyamino acids such as serine and threonine; sulfur-containing amino acids such as cysteine and methionion; monoaminodicarboxylic acids such as aspartic acid and glutamic acid; diaminomonocarboxylic acids such as lysine. Aliphatic amino acids such as are preferred examples. Among these, glycine, alanine, and glutamic acid are particularly preferable in view of the appearance color of powder, stability, and feeling of use.
【手続補正3】[Procedure 3]
【補正対象書類名】明細書[Document name to be amended] Statement
【補正対象項目名】0016[Correction target item name] 0016
【補正方法】変更[Correction method] Change
【補正内容】[Correction content]
【0016】前記防腐剤・酸化防止剤としてはたとえ
ば、パラオキシ安息香酸エステル、デヒドロ酢酸(およ
びその塩類)、ソルビン酸(およびその塩類)、塩化リ
ゾチーム、ジブチルヒドロキシトルエン、ブチルヒドロ
キシアニソールなどがあげられる。[0016] As the preservative antioxidants example, parahydroxybenzoate ester, dehydroacetic acid (and its salts), sorbic acid (and salts thereof), lysozyme chloride, dibutyl hydroxy toluene and butyl hydroxy anisole and the like ..
Claims (5)
ることを特徴とする化粧料。1. A cosmetic comprising an amino acid metal salt as an active ingredient.
0.01〜95重量%であることを特徴とする請求項1記載の
化粧料。2. The amount of the amino acid metal salt compounded is the total amount of the cosmetic.
The cosmetic according to claim 1, which is 0.01 to 95% by weight.
であることを特徴とする請求項1記載の化粧料。3. The particle size of the amino acid metal salt is 0.01 to 50 μm.
The cosmetic according to claim 1, wherein
とを特徴とする請求項1記載の化粧料。4. The cosmetic according to claim 1, wherein the amino acid metal salt is zinc glycine.
ることを特徴とする請求項1記載の化粧料。5. The cosmetic according to claim 1, wherein the amino acid metal salt is zinc glutamate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3261987A JPH0597645A (en) | 1991-10-09 | 1991-10-09 | Cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3261987A JPH0597645A (en) | 1991-10-09 | 1991-10-09 | Cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0597645A true JPH0597645A (en) | 1993-04-20 |
Family
ID=17369432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3261987A Pending JPH0597645A (en) | 1991-10-09 | 1991-10-09 | Cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0597645A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997020539A1 (en) * | 1995-12-05 | 1997-06-12 | Kabushiki Kaisya Advance | Cosmetic preparation |
| JP2009269840A (en) * | 2008-05-02 | 2009-11-19 | Kao Corp | Powdery cosmetic product |
-
1991
- 1991-10-09 JP JP3261987A patent/JPH0597645A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997020539A1 (en) * | 1995-12-05 | 1997-06-12 | Kabushiki Kaisya Advance | Cosmetic preparation |
| JP2009269840A (en) * | 2008-05-02 | 2009-11-19 | Kao Corp | Powdery cosmetic product |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1341147C (en) | Sunscreen compositions | |
| US8858922B2 (en) | Broad spectrum UVA stable, non-toxic, zinc oxide based complex | |
| CN101896159B (en) | Cosmetics for protecting the skin against environmental influences | |
| JPS60231607A (en) | Antisuntan cosmetic | |
| WO2010110020A1 (en) | Sunscreen cosmetic | |
| US6540986B2 (en) | Sunscreen compositions | |
| KR102092297B1 (en) | Cosmetics of water insoluble sponge containing cosmetic compositions of sunscreen function | |
| KR20180031173A (en) | Make-up cosmetic composition comprising scoria powder | |
| JPH08268839A (en) | Zinc oxide-coated extender pigment and cosmetics containing the same | |
| TW482681B (en) | Powder coated with sparingly soluble ultraviolet absorber | |
| KR101598623B1 (en) | UV blocking agents containing ethylhexyltriazone and the preparation method thereof, and the cosmetic composition containing the same | |
| JPH0621057B2 (en) | Cosmetic composition | |
| CA2296625C (en) | Sweat resistant sunblock and antioxidant composition | |
| JP2003267854A (en) | Bleaching cosmetic | |
| JPH0597645A (en) | Cosmetic | |
| JP3736970B2 (en) | Coated powder and cosmetic comprising the same | |
| US6159481A (en) | Sweat resistant sunblock and antioxidant composition | |
| JPH11199425A (en) | Cosmetic | |
| JPH07206651A (en) | Ultraviolet absorber | |
| JP3207996B2 (en) | Sunscreen cosmetics | |
| JP4205206B2 (en) | Coated powder and cosmetic comprising the same | |
| JPS6239517A (en) | Cosmetic | |
| JP4516729B2 (en) | Iron phosphate-containing composite and cosmetic containing the same | |
| JPH11116457A (en) | Cosmetic | |
| JPH1135326A (en) | Molybdenum or tungsten-containing titanium oxide particulate and cortex external preparation containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |